Follow the 亚虹医药 share price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 亚虹医药 has logged 8 insider filings. Market capitalisation: €7.1bn. The latest transaction was reported on 21 July 2026 (Sale). Among the most active insiders: PAN KE. All data is free.
8
Insider Decl.
n/a
Thresholds
€156,678
4 ops.
Buy Volume
€69,620
4 ops.
Sell Volume
14Σ signal
Buys €156,678€69,620 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,743 of 29,064 companies
34.7
score / 100
Value
20
Quality
50
FCF yld-6.3%
Earn yld-6.1%
EV/EBITDA·
ROE-28%
Gross mgn74%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.